Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Novel melatonergic agents described by Bristol-Myers Squibb

June 26, 1997

Naratriptan highlighted at headache congress; introduced in U.K.

June 26, 1997

RTP Pharma receives U.S. patent for new formulation of propofol

June 25, 1997

Single efficacy trial for transdermal buspirone required by FDA

June 25, 1997

IND approved for multiple sclerosis drug from TCAR program

June 25, 1997

Preclinical and preliminary clinical results reported for alniditan

June 25, 1997

Zolmitriptan: a new antimigraine agent with peripheral and central sites of action

June 25, 1997

5-HT1B receptor antagonists claimed by SKB

June 25, 1997

Centrally active muscarinic agents from American Home Products

June 25, 1997

NOS inhibitors disclosed by Astra for stroke and other disorders

June 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...